CELCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Celcuity Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$57.12+0.54 (+0.95%)
Close on Oct 19, 2026
- Market cap
- $3.13B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$5.16 (+9.93%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $3.13B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -6.14%
Fundamentals
- Net income
- -$226.48M
- EPS, diluted
- -$4.30
- Free cash flow
- -$192.16M
- Book value per share
- -$0.23
- Diluted shares
- 55M
Eleven years at a glance
Fiscal years 2015 to 2025 and trailing twelve months, USD
Operating income
-$208.68M
Net income
-$226.48M
EPS, diluted
-$4.30
Free cash flow
-$192.16M
Reported periodTrailing twelve months